110072-96-3

Basic information

• Product Name: 5-(NEO-PENTYL)HYDANTOIN
• Synonyms: 5-(NEO-PENTYL)HYDANTOIN;5-(3-Amyl)hydantoin;(+/-)-5-(1-Ethylpropyl)-2,4-iMidazolidinedione;(+/-)-5-(1-Ethylpropyl)hydantoin
• CAS NO: 110072-96-3
• Molecular Formula: C8H14N2O2
• Molecular Weight: 170.20896
• Product Categories: Hydantoins and Derivatives;Hydantoins & Derivatives
• Mol File: 110072-96-3.mol

Chemical Properties

• Melting Point: 178-180°C
• Appearance: /
• Density: 1.071±0.06 g/cm3(Predicted)
• Storage Temp.: Refrigerator
• Solubility: DMSO, Ethyl Acetate, Methanol
• PKA: 8.83±0.10(Predicted)
• CAS DataBase Reference: 5-(NEO-PENTYL)HYDANTOIN(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(NEO-PENTYL)HYDANTOIN(110072-96-3)
• EPA Substance Registry System: 5-(NEO-PENTYL)HYDANTOIN(110072-96-3)

Safety Data

• Hazardous Substances Data: 110072-96-3(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
5-(NEO-PENTYL)HYDANTOIN is used as a synthetic building block for the creation of various organic compounds. Its unique structure and properties allow it to be a versatile component in the synthesis of a wide range of molecules, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-(NEO-PENTYL)HYDANTOIN is used as an intermediate in the synthesis of various drugs. Its chemical properties make it a suitable candidate for the development of new medications, potentially contributing to the treatment of various diseases and conditions.
Used in Agrochemical Industry:
5-(NEO-PENTYL)HYDANTOIN is also utilized in the agrochemical industry for the synthesis of compounds used in the development of pesticides, herbicides, and other agricultural chemicals. Its role in this industry is crucial for the creation of effective and environmentally friendly solutions to protect crops and enhance agricultural productivity.
Used in Specialty Chemicals:
In the specialty chemicals sector, 5-(NEO-PENTYL)HYDANTOIN is employed as a key component in the synthesis of various high-value chemicals. These chemicals are used in a wide range of applications, including coatings, adhesives, and other industrial materials, showcasing the compound's versatility and importance in the chemical industry.

Upstream product

• 97-96-1 2-Ethylbutyraldehyde 
• 773837-37-9 sodium cyanide 
• 506-87-6 ammonium carbonate 
• 96-22-0 pentan-3-one 

Downstream Products

• 1916-96-7 β,β-Diaethyl-N-benzyl-alanin 
• 14328-54-2 2-(S)-amino-3-ethyl-pentanoic acid 
• 785735-06-0 2-benzyloxycarbonylamino-3-ethylpentanoic acid 
• 1357010-67-3 tert-butyl 4-benzyloxycarbonylamino-5-ethyl-3-oxoheptanoate 
• 1357010-68-4 1-tert-butyl 4-ethyl 2-(2-benzyloxycarbonylamino-3-ethylpentanoyl)-3-methylsuccinate 
• 1357010-69-5 ethyl 5-benzyloxycarbonylamino-6-ethyl-2-methyl-4-oxo-octanoate 
• 1357010-70-8 benzyl [2-ethyl-1-(5-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)butyl]carbamate 
• 1357010-58-2 5-(1-ethylpropyl)-2-(4-methoxy-2-methylphenyl)-3,7-dimethylimidazo[1,5-b]pyridazine 

Relevant articles and documents

Pyrazole compounds as well as preparation method and application thereof

The invention provides pyrazole compounds with neuraminidase (NA) inhibitory activity as well as a preparation method and application thereof in pharmacy, and specifically relates to a compound shownin a formula (I), and pharmaceutically acceptable salt, an isomer and a prodrug thereof, and the definition of various groups is as described in the description. The invention further relates to pharmaceutic preparations and pharmaceutical compositions of the compounds and application of the pharmaceutic preparations and the pharmaceutical compositions in treatment of diseases caused by influenzavirus infection. The pyrazole compounds provided by the invention have good inhibitory effects on H1N1 influenza A virus infected cells.

Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF1) receptor antagonists

To identify structurally novel corticotropin-releasing factor 1 (CRF 1) receptor antagonists, a series of bicyclic core analogs pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f]triazin-4(3H)-ones, which were designed based on a monocyclic core antag

Production of chirally pure alpha-amino acids and N-sulfonyl alpha-amino acids

Methods for production of chirally pure α-amino acids and N-sulfonyl α-amino acids are described. An aldehyde and a cyanide salt are reacted with an α-methylbenzylamine to afford product. The product reacts with a strong acid, neutralized, and extracted.

Production of chirally pure α-amino acids and N-sulfonyl α-amino acids

Methods for production of chirally pure α-amino acids and N-sulfonyl α-amino acids are described. An aldehyde and a cyanide salt are reacted with an α-methylbenzylamine to afford product. The product reacts with a strong acid, neutralized, and extracted.

Heterocyclic sulfonamide inhibitors of beta amyloid production

Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs there